Genetic markers associated with early cancer-specific mortality following prostatectomy-Reference-Cited by-同舟云学术

Genetic markers associated with early cancer-specific mortality following prostatectomy

Published:2013-04-22 Issue:13 Volume:119 Page:2405-2412
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Liu Wennuan¹²,Xie Chunmei C.¹²,Thomas Christopher Y.³,Kim Seong-Tae¹²,Lindberg Johan⁴,Egevad Lars⁵,Wang Zhong¹²,Zhang Zheng¹²,Sun Jishan¹²,Sun Jielin¹²,Koty Patrick P.¹²⁶,Kader A. Karim⁷,Cramer Scott D.⁸,Bova G. Steven⁹,Zheng S. Lilly¹²,Grönberg Henrik⁴,Isaacs William B.¹⁰,Xu Jianfeng¹²¹¹

Affiliation:

1. Center for Cancer Genomics; Wake Forest University School of Medicine; Winston-Salem North Carolina

2. Center for Genomics and Personalized Medicine Research; Wake Forest University School of Medicine; Winston-Salem North Carolina

3. Department of Hematology and Oncology; Wake Forest University School of Medicine; Winston-Salem North Carolina

4. Department of Medical Epidemiology and Biostatistics; Karolinska Institute; Stockholm Sweden

5. Department of Pathology and Cytology; Karolinska University Hospital; Stockholm Sweden

6. Department of Pediatrics; Wake Forest University School of Medicine; Winston-Salem North Carolina

7. Department of Surgery; University of California San Diego; San Diego California

8. Department of Pharmacology; University of Colorado; Aurora Colorado

9. Institute of Biomedical Technology; University of Tampere; Tampere Finland

10. Brady Urological Institute; Johns Hopkins Medical Institutions; Baltimore Maryland

11. Department of Urology; Wake Forest University School of Medicine; Winston-Salem North Carolina

Funder

National Institutes of Health

Department of Defense

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27954/fullpdf

Reference25 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer;Boorjian;Cancer,2011

3. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era;Kibel;J Urol,2012

4. Radical prostatectomy versus watchful waiting in early prostate cancer;Bill-Axelson;N Engl J Med,2011

5. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate;Carver;Nat Genet,2009

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical support for tumor protein D52 as a cancer vaccine antigen;Human Vaccines & Immunotherapeutics;2023-10-30

2. Quantitative diffusion MRI in prostate cancer: Image quality, what we can measure and how it improves clinical assessment;European Journal of Radiology;2023-10

3. Generating a Murine PTEN Null Cell Line to Discover the Key Role of p110β-PAK1 in Castration-Resistant Prostate Cancer Invasion;Molecular Cancer Research;2023-08-22

4. A harmonized resource of integrated prostate cancer clinical, -omic, and signature features;Scientific Data;2023-07-05

5. Prognostic Values of Gene Copy Number Alterations in Prostate Cancer;Genes;2023-04-22